Celine F Santiago1,2, Inken G Huttner1,2, Diane Fatkin3,4,5. 1. Molecular Cardiology and Biophysics Division, Victor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia. 2. School of Clinical Medicine, UNSW Medicine and Health UNSW Sydney, Kensington, NSW, Australia. 3. Molecular Cardiology and Biophysics Division, Victor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia. d.fatkin@victorchang.edu.au. 4. School of Clinical Medicine, UNSW Medicine and Health UNSW Sydney, Kensington, NSW, Australia. d.fatkin@victorchang.edu.au. 5. Cardiology Department, St. Vincent's Hospital, Darlinghurst, NSW, Australia. d.fatkin@victorchang.edu.au.
Abstract
PURPOSE OF REVIEW: Truncating TTN variants (TTNtv) are the most common genetic cause of dilated cardiomyopathy (DCM), but the underlying mechanisms are incompletely understood and effective therapeutic strategies are lacking. Here we review recent data that shed new light on the functional consequences of TTNtv and how these effects may vary with mutation location. RECENT FINDINGS: Whether TTNtv act by haploinsufficiency or dominant negative effects has been hotly debated. New evidence now implicates both mechanisms in TTNtv-related DCM, showing reduced titin content and persistent truncated titin that may be incorporated into protein aggregates. The extent to which aggregate formation and protein quality control defects differ with TTNtv location and contribute to contractile dysfunction is unresolved. TTNtv-associated DCM has a complex etiology that involves varying combinations of wild-type titin deficiency and dominant negative effects of truncated mutant titin. Therapeutic strategies to improve protein handling may be beneficial in some cases.
PURPOSE OF REVIEW: Truncating TTN variants (TTNtv) are the most common genetic cause of dilated cardiomyopathy (DCM), but the underlying mechanisms are incompletely understood and effective therapeutic strategies are lacking. Here we review recent data that shed new light on the functional consequences of TTNtv and how these effects may vary with mutation location. RECENT FINDINGS: Whether TTNtv act by haploinsufficiency or dominant negative effects has been hotly debated. New evidence now implicates both mechanisms in TTNtv-related DCM, showing reduced titin content and persistent truncated titin that may be incorporated into protein aggregates. The extent to which aggregate formation and protein quality control defects differ with TTNtv location and contribute to contractile dysfunction is unresolved. TTNtv-associated DCM has a complex etiology that involves varying combinations of wild-type titin deficiency and dominant negative effects of truncated mutant titin. Therapeutic strategies to improve protein handling may be beneficial in some cases.
Authors: Ryan Hohman; Michael Shea; Marina Kozak; Samantha Roberts; Jeff Allen; Ellen Sigal Journal: Sci Transl Med Date: 2015-11-11 Impact factor: 17.956
Authors: Inken G Huttner; Louis W Wang; Celine F Santiago; Claire Horvat; Renee Johnson; Delfine Cheng; Marion von Frieling-Salewsky; Karen Hillcoat; Timothy J Bemand; Gunjan Trivedi; Filip Braet; Dan Hesselson; Kevin Alford; Christopher S Hayward; J G Seidman; Christine E Seidman; Michael P Feneley; Wolfgang A Linke; Diane Fatkin Journal: Circ Genom Precis Med Date: 2018-08
Authors: Wei-Dong Le; Pingyi Xu; Joseph Jankovic; Hong Jiang; Stanley H Appel; Roy G Smith; Demetrios K Vassilatis Journal: Nat Genet Date: 2002-12-23 Impact factor: 38.330
Authors: Rahul Goli; Jian Li; Jeff Brandimarto; Lisa D Levine; Valerie Riis; Quentin McAfee; Steven DePalma; Alireza Haghighi; J G Seidman; Christine E Seidman; Daniel Jacoby; George Macones; Daniel P Judge; Sarosh Rana; Kenneth B Margulies; Thomas P Cappola; Rami Alharethi; Julie Damp; Eileen Hsich; Uri Elkayam; Richard Sheppard; Jeffrey D Alexis; John Boehmer; Chizuko Kamiya; Finn Gustafsson; Peter Damm; Anne S Ersbøll; Sorel Goland; Denise Hilfiker-Kleiner; Dennis M McNamara; Zolt Arany Journal: Circulation Date: 2021-04-20 Impact factor: 29.690
Authors: Jun Zou; Diana Tran; Mai Baalbaki; Ling Fung Tang; Annie Poon; Angelo Pelonero; Erron W Titus; Christiana Yuan; Chenxu Shi; Shruthi Patchava; Elizabeth Halper; Jasmine Garg; Irina Movsesyan; Chaoying Yin; Roland Wu; Lisa D Wilsbacher; Jiandong Liu; Ronald L Hager; Shaun R Coughlin; Martin Jinek; Clive R Pullinger; John P Kane; Daniel O Hart; Pui-Yan Kwok; Rahul C Deo Journal: Elife Date: 2015-10-16 Impact factor: 8.140
Authors: Arjan Pol; G Herma Renkema; Albert Tangerman; Edwin G Winkel; Udo F Engelke; Arjan P M de Brouwer; Kent C Lloyd; Renee S Araiza; Lambert van den Heuvel; Heymut Omran; Heike Olbrich; Marijn Oude Elberink; Christian Gilissen; Richard J Rodenburg; Jörn Oliver Sass; K Otfried Schwab; Hendrik Schäfer; Hanka Venselaar; J Silvia Sequeira; Huub J M Op den Camp; Ron A Wevers Journal: Nat Genet Date: 2017-12-18 Impact factor: 38.330
Authors: Charles A Tharp; Mary E Haywood; Orfeo Sbaizero; Matthew R G Taylor; Luisa Mestroni Journal: Front Physiol Date: 2019-11-28 Impact factor: 4.566